Effect of combined doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping

Psychopharmacology

Volumn 232, Issue 24, 2015, Pages 4445-4454

  Rock, Erin M ^a   Limebeer, Cheryl L ^a   Parker, Linda A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Acute nausea; Anticipatory nausea; CBDA; Conditioned taste avoidance; Locomotor activity; THC

Indexed keywords

CANNABIDIOLIC ACID; CANNABINOID; DELTA9(11) TETRAHYDROCANNABINOL; LITHIUM CHLORIDE; UNCLASSIFIED DRUG; ANTIEMETIC AGENT; DRONABINOL; SACCHARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICIPATORY NAUSEA AND VOMITING; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; LOCOMOTION; NONHUMAN; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; TREATMENT OUTCOME; ANIMAL; CHEMICALLY INDUCED; COMBINATION DRUG THERAPY; CONDITIONING; DISEASE MODEL; DRUG EFFECTS; MALE; NAUSEA; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIEMETICS; CANNABINOIDS; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DRONABINOL; DRUG THERAPY, COMBINATION; LITHIUM CHLORIDE; MALE; NAUSEA; RATS; RATS, SPRAGUE-DAWLEY; SACCHARIN;

EID: 84947492287     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-015-4080-1     Document Type: Article

References (54)

1. Aapro MS, Molassiotis A, Olver I (2005) Anticipatory nausea and vomiting. Support Care Cancer 13:117-121. doi: 10.1007/s00520-004-0745-8
2. Bolognini D, Rock EM, Cluny NL, Cascio MG, Limebeer CL, Duncan M, Stott CG, Javid FA, Parker LA, Pertwee RG (2013) Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. Br J Pharmacol 168:1456-1470. doi: 10.1111/bph.12043
3. Bornheim LM, Correia MA (1990) Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol. Mol Pharmacol 38(3):319-326
4. Bornheim LM, Correia MA (1991) Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse: a possible member of the cytochrome P-450IIC subfamily. Mol Pharmacol 40(2):228-234
5. Breslin PA, Spector AC, Grill HJ (1992) A quantitative comparison of taste reactivity behaviors to sucrose before and after lithium chloride pairings: a unidimensional account of palatability. Behav Neurosci 106:820-836
6. Elwood C, Devauchelle P, Elliott J, Freiche V, German AJ, Gualtieri M et al (2010) Emesis in dogs: a review. J Small Anim Pract 51:4-22. doi: 10.1111/j.1748-5827.2009.00820.x, Review
7. Englund A, Morrison PD, Nottage J, Hague D, Kane F, Bonaccorso S, Stone JM, Reichenberg A, Brenneisen R, Holt D, Feilding A, Walker L, Murray RM, Kapur S (2013) Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. J Psychopharmacol 27:19-27. doi: 10.1177/0269881112460109
8. Foubert J, Vaessen G (2005) Nausea: the neglected symptom? Eur J Oncol Nurs 9:21-32. doi: 10.1016/j.ejon.2004.03.006
9. Grill HJ, Norgren R (1978) The taste reactivity test. I. Mimetic responses to gustatory stimuli in neurologically normal rats. Brain Res 143:263-279
10. Hesketh PJ, Van Belle S, Aapro M, Tattersall FD, Naylor RJ, Hargreaves R, Carides AD, Evans JK, Horgan KJ (2003) Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. Eur J Cancer 39:1074-1080
11. Hindocha C, Freeman TP, Schafer G, Gardener C, Das RK, Morgan CJ, Curran HV (2015) Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users. Eur Neuropsychopharmacol 25:325-334. doi: 10.1016/j.euroneuro.2014.11.014
12. Jordan K, Kasper C, Schmoll HJ (2005) Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment. Eur J Cancer 41:199-205. doi: 10.1016/j.ejca.2004.09.026
13. Katsidoni V, Kastellakis A, Panagis G (2013) Biphasic effects of Delta9-tetrahydrocannabinol on brain stimulation reward and motor activity. Int J Neuropsychopharmacol 16:2273-2284. doi: 10.1017/S1461145713000709
14. 9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. Psychopharmacology (Berlin) 218(2):443-457
15. Limebeer CL, Parker LA (2000) The antiemetic drug ondansetron interferes with lithium-induced conditioned rejection reactions, but not lithium-induced taste avoidance in rats. J Exp Psychol Anim Behav Process 26:371-384
16. Limebeer CL, Parker LA (2003) The 5-HT1A agonist 8-OH-DPAT dose-dependently interferes with the establishment and the expression of lithium-induced conditioned rejection reactions in rats. Psychopharmacology (Berlin) 166:120-126. doi: 10.1007/s00213-002-1309-6
17. Limebeer CL, Hall G, Parker LA (2006) Exposure to a lithium-paired context elicits gaping in rats: a model of anticipatory nausea. Physiol Behav 88:398-403. doi: 10.1016/j.physbeh.2006.04.014
18. Limebeer CL, Krohn JP, Cross-Mellor S, Litt DE, Ossenkopp KP, Parker LA (2008) Exposure to a context previously associated with nausea elicits conditioned gaping in rats: a model of anticipatory nausea. Behav Brain Res 187:33-40. doi: 10.1016/j.bbr.2007.08.024
19. Limebeer CL, Vemuri VK, Bedard H, Lang ST, Ossenkopp KP, Makriyannis A, Parker LA (2010) Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats. Br J Pharmacol 161:336-349. doi: 10.1111/j.1476-5381.2010.00885.x
20. Malik IA, Khan WA, Qazilbash M, Ata E, Butt A, Khan MA (1995) Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. Am J Clin Oncol 18:170-175
21. Malone DT, Jongejan D, Taylor DA (2009) Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats. Pharmacol Biochem Behav 93:91-96. doi: 10.1016/j.pbb.2009.04.010
22. Morrow GR, Roscoe JA, Hynes HE, Flynn PJ, Pierce HI, Burish T (1998a) Progress in reducing anticipatory nausea and vomiting: a study of community practice. Support Care Cancer 6:46-50
23. Morrow GR, Roscoe JA, Kirshner JJ, Hynes HE, Rosenbluth RJ (1998b) Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics. Support Care Cancer 6:244-247
24. Nesse RM, Carli T, Curtis GC, Kleinman PD (1980) Pretreatment nausea in cancer chemotherapy: a conditioned response? Psychosom Med 42:33-36
25. Parker LA (1995) Rewarding drugs produce taste avoidance, but not taste aversion. Neurosci Biobehav Rev 19:143-157
26. Parker LA (2014) Conditioned flavor avoidance and conditioned gaping: rat models of conditioned nausea. Eur J Pharmacol 722:122-133. doi: 10.1016/j.ejphar.2013.09.070
27. Parker LA, Mechoulam R (2003) Cannabinoid agonists and antagonists modulate lithium-induced conditioned gaping in rats. Integr Physiol Behav Sci 38:133-145
28. Parker LA, Mechoulam R, Schlievert C, Abbott L, Fudge ML, Burton P (2003) Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea. Psychopharmacology (Berlin) 166:156-162. doi: 10.1007/s00213-002-1329-2
29. Parker LA, Kwiatkowska M, Burton P, Mechoulam R (2004) Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew). Psychopharmacology (Berlin) 171:156-161. doi: 10.1007/s00213-003-1571-2
30. Pavlov IP (1927) Conditioned reflexes: an investigation of the physiological activity of the cerebral cortex. Oxford University Press, Oxford
31. Poli-Bigelli S, Rodrigues-Pereira J, Carides AD, Julie Ma G, Eldridge K, Hipple A, Evans JK, Horgan KJ, Lawson F, Aprepitant Protocol 054 Study Group (2003) Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America. Cancer 97:3090-3098. doi: 10.1002/cncr.11433
32. Potter DJ, Clark P, Brown MB (2008) Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. J Forensic Sci 53:90-94. doi: 10.1111/j.1556-4029.2007.00603.x
33. Razavi D, Delvaux N, Farvacques C, De Brier F, Van Heer C, Kaufman L, Derde MP, Beauduin M, Piccart M (1993) Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. J Clin Oncol 11:1384-1390
34. Reid MJ, Bornheim LM (2001) Cannabinoid-induced alterations in brain disposition of drugs of abuse. Biochem Pharmacol 61(11):1357-1367
35. Rock EM, Parker LA (2013a) Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats. Br J Pharmacol 169:685-692. doi: 10.1111/bph.12162
36. Rock EM, Parker LA (2013b) Suppression of lithium chloride-induced conditioned gaping (a model of nausea-induced behaviour) in rats (using the taste reactivity test) with metoclopramide is enhanced by cannabidiolic acid. Pharmacol Biochem Behav 111:84-89. doi: 10.1016/j.pbb.2013.08.012
37. Rock EM, Parker LA (2015) Synergy between cannabidiol, cannabidiolic acid, and Delta(9)-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew). Behav Neurosci 129:368-370. doi: 10.1037/bne0000057
38. Rock EM, Limebeer CL, Mechoulam R, Piomelli D, Parker LA (2008) The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat. Psychopharmacology (Berlin) 196:389-395. doi: 10.1007/s00213-007-0970-1
39. Rock EM, Bolognini D, Limebeer CL, Cascio MG, Anavi-Goffer S, Fletcher PJ, Mechoulam R, Pertwee RG, Parker LA (2012) Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus. Br J Pharmacol 165:2620-2634. doi: 10.1111/j.1476-5381.2011.01621.x
40. Rock EM, Kopstick RL, Limebeer CL, Parker LA (2013) Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus. Br J Pharmacol 170:641-648. doi: 10.1111/bph.12316
41. Rock EM, Limebeer CL, Navaratnam R, Sticht MA, Bonner N, Engeland K, Downey R, Morris H, Jackson M, Parker LA (2014a) A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping. Psychopharmacology (Berlin) 231:3207-3215. doi: 10.1007/s00213-014-3498-1
42. Rock EM, Limebeer CL, Parker LA (2014b) Anticipatory nausea in animal models: a review of potential novel therapeutic treatments. Exp Brain Res 232:2511-2534. doi: 10.1007/s00221-014-3942-9
43. Russo E, Guy GW (2006) A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses 66:234-246. doi: 10.1016/j.mehy.2005.08.026
44. Sharkey KA, Darmani NA, Parker LA (2014) Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. Eur J Pharmacol 722:134-146. doi: 10.1016/j.ejphar.2013.09.068
45. Sotelo C, Cholley B, El Mestikawy S, Gozlan H, Hamon M (1990) Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur J Neurosci 2:1144-1154
46. Taffe MA, Creehan KM, Vandewater SA (2015) Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Delta(9) -tetrahydrocannabinol in Sprague-Dawley rats. Br J Pharmacol 172:1783-1791. doi: 10.1111/bph.13024
47. Thamm DH, Vail DM (2007) Aftershocks of cancer chemotherapy: managing adverse effects. J Am Anim Hosp Assoc 43:1-7. doi: 10.5326/43.6.toc
48. Tomiyasu H, Takahashi M, Fujino Y, Ohno K, Tsujimoto H (2010) Gastrointestinal and hematologic adverse events after administration of vincristine, cyclophosphamide, and doxorubicin in dogs with lymphoma that underwent a combination multidrug chemotherapy protocol. J Vet Med Sci 72:1391-1397
49. Travers JB, Norgren R (1986) Electromyographic analysis of the ingestion and rejection of sapid stimuli in the rat. Behav Neurosci 100:544-555
50. Vann RE, Gamage TF, Warner JA, Marshall EM, Taylor NL, Martin BR, Wiley JL (2008) Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol. Drug Alcohol Depend 94:191-198. doi: 10.1016/j.drugalcdep.2007.11.017
51. Varvel SA, Wiley JL, Yang R, Bridgen DT, Long K, Lichtman AH, Martin BR (2006) Interactions between THC and cannabidiol in mouse models of cannabinoid activity. Psychopharmacology (Berlin) 186:226-234. doi: 10.1007/s00213-006-0356-9
52. Verge D, Daval G, Patey A, Gozlan H, el Mestikawy S, Hamon M (1985) Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. Eur J Pharmacol 113:463-464
53. Wright MJ Jr, Vandewater SA, Taffe MA (2013) Cannabidiol attenuates deficits of visuospatial associative memory induced by Delta(9) tetrahydrocannabinol. Br J Pharmacol 170:1365-1373. doi: 10.1111/bph.12199
54. Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG (1982) Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. Psychopharmacology (Berlin) 76:245-250